HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Sunose Selected Research

Reperfusion Injury

9/2001Novel nitric oxide donor (FK409) ameliorates liver damage during extended liver resection with warm ischemia in dogs.
9/2001The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs.
8/2001A spontaneous nitric oxide donor ameliorates small bowel ischemia-reperfusion injury in dogs.
2/2001Selective cyclooxygenase-2 inhibitor ameliorates warm ischemia-reperfusion injury of the canine liver.
2/2001Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model.
1/2001The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model.
1/2001FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs.
11/2000The effect of cyclooxygenase 2 inhibitor (FK3311) on ischemia-reperfusion injury with hepatectomy in dogs.
11/2000Effects of FR167653 on ischemia-reperfusion injury in canine lung transplantation models.
11/2000Effect of FK3311 on ischemia-reperfusion injury in canine pulmonary models.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Sunose Research Topics

Disease

13Reperfusion Injury
09/2001 - 09/2000
9Ischemia
11/2001 - 03/2000
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2012
1Hepatocellular Carcinoma (Hepatoma)
03/2006
1Anastomotic Leak
09/2000

Drug/Important Bio-Agent (IBA)

5FK 3311IBA
09/2001 - 11/2000
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2001 - 11/2000
4FR 167653IBA
11/2000 - 09/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2001 - 03/2000
2Arachidonic Acid (Vitamin F)IBA
10/2001 - 09/2001
2FR 128998IBA
01/2001 - 11/2000
2Interleukin-8 (Interleukin 8)IBA
11/2000 - 09/2000
2Messenger RNA (mRNA)IBA
11/2000 - 09/2000
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
08/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2006
1CytokinesIBA
10/2001
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
09/2001
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
09/2001
1Nitric Oxide DonorsIBA
08/2001
1Platelet Activating FactorIBA
01/2001
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2001
1Interleukin-1 (Interleukin 1)IBA
09/2000
1InterleukinsIBA
09/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2000

Therapy/Procedure

3Warm Ischemia
08/2001 - 01/2001
2Hepatectomy
03/2006 - 11/2000
2Lung Transplantation
11/2000 - 09/2000
1Transplantation
11/2001
1Lymph Node Excision (Lymph Node Dissection)
09/2000
1Esophagectomy
09/2000